InvestorsHub Logo
Followers 62
Posts 7579
Boards Moderated 1
Alias Born 01/02/2003

Re: None

Saturday, 05/06/2023 9:52:07 AM

Saturday, May 06, 2023 9:52:07 AM

Post# of 427043
Some important questions about China and the Amarin-Mochida agreement that we still awaiting information on..

1. What more is required of Vascepa to attain approval in China?
2. What can Amarin expect for reimbursement of Vascepa in China?
3. Will Mochida release their own version of EPA(Epadel) in competition with Amarin's Vascepa in China?
4. When MND-2119 is approved in China, will Amarin be able to market it there in competition with Mochida?
5. Will Mochida be able to market MND-2119 in the U.S.?
6. Are there royalties due to Mochida for the marketing of MND-2119 in the U.S or elsewhere?.
7. How does a change of ownership impact the Amarin-Mochida deal, if at all?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News